Awakn Life Sciences CEO Anthony Tennyson: Developing and Delivering the Next Generation of Addiction Treatments Video Interview
NATERA Plant-Based Products to Launch at Denny’s Restaurants across Canada Following Menu Test in B.C. Biotech Investing
AbbVie Receives a Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health pan-Canadian Oncology Drug Review Expert Review Committee for VENCLEXTA® in Combination with azacitidine for Acute Myeloid Leukemia Patients Biotech Investing
NATERA Plant-Based Products to Launch at Denny's Restaurants across Canada Following Menu Test in B.C. Biotech Investing
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. Biotech Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Trillium Therapeutics, Inc. Buyout Biotech Investing
TRILLIUM ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of TRIL and Encourages Investors to Contact the Firm Biotech Investing
European Commission Approves RINVOQ® as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis Biotech Investing
Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis Biotech Investing
TRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium Therapeutics Inc. - TRIL Biotech Investing
